Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

NYSE:CBNA - New York Stock Exchange, Inc. - US15746L1008 - Common Stock - Currency: USD

25.43  -0.04 (-0.16%)

After market: 25.43 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CBNA. CBNA was compared to 396 industry peers in the Banks industry. While CBNA seems to be doing ok healthwise, there are quite some concerns on its profitability. CBNA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CBNA had positive earnings in the past year.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

CBNA's Return On Assets of 1.54% is amongst the best of the industry. CBNA outperforms 90.66% of its industry peers.
CBNA's Return On Equity of 17.53% is amongst the best of the industry. CBNA outperforms 96.21% of its industry peers.
Industry RankSector Rank
ROA 1.54%
ROE 17.53%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

With an excellent Profit Margin value of 39.35%, CBNA belongs to the best of the industry, outperforming 94.95% of the companies in the same industry.
CBNA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 39.35%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBNA has more shares outstanding than it did 1 year ago.
There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC10.68%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 132.05% over the past year.
Looking at the last year, CBNA shows a very strong growth in Revenue. The Revenue has grown by 70.68%.
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CBNA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.96% yearly.
The Revenue is expected to grow by 8.17% on average over the next years. This is quite good.
EPS Next Y-38.57%
EPS Next 2Y-6.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.35%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

CBNA is valuated cheaply with a Price/Earnings ratio of 6.19.
CBNA's Price/Earnings ratio is rather cheap when compared to the industry. CBNA is cheaper than 95.71% of the companies in the same industry.
CBNA is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.79, the valuation of CBNA can be described as very cheap.
Based on the Price/Forward Earnings ratio, CBNA is valued cheaper than 89.14% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CBNA to the average of the S&P500 Index (22.13), we can say CBNA is valued rather cheaply.
Industry RankSector Rank
PE 6.19
Fwd PE 6.79
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as CBNA's earnings are expected to decrease with -6.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBNA!.
Industry RankSector Rank
Dividend Yield N/A

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (6/13/2025, 8:04:00 PM)

After market: 25.43 0 (0%)

25.43

-0.04 (-0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-28 2025-04-28/amc
Earnings (Next)N/A N/A
Inst Owners45.66%
Inst Owner Change27.35%
Ins Owners25.13%
Ins Owner Change4.76%
Market Cap166.82M
Analysts80
Price Target30.26 (18.99%)
Short Float %0.42%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.27%
Min EPS beat(2)5.17%
Max EPS beat(2)53.38%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.13%
Min Revenue beat(2)15.06%
Max Revenue beat(2)25.2%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.63%
EPS NY rev (1m)0%
EPS NY rev (3m)13.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.03%
Valuation
Industry RankSector Rank
PE 6.19
Fwd PE 6.79
P/S 2.47
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)4.11
EY16.16%
EPS(NY)3.75
Fwd EY14.73%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.29
BVpS23.1
TBVpS23.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 17.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 39.35%
GM N/A
FCFM N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC10.68%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-38.57%
EPS Next 2Y-6.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-0.35%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A